Monde réel et Dernières phases
Unlocking real world insights to drive evidence-based decisions
Dans le cadre du développement biopharmaceutique, la clé de l’accès aux marchés est la création d’une solide proposition commerciale. Les données probantes du monde réel sont à la base de cette proposition pour les payeurs, les médecins, les patients et, de plus en plus, les organismes de réglementation, car ils reconnaissent la valeur de ces données.
Committed to excellence in real world research
Our Real World team consists of 220+ operations experts, epidemiologists and biostatisticians, and data experts and analysts – all focused on providing innovative solutions and delivering exceptional results.
Real World Expertise
With seasoned expertise in RWLP, we excel in in navigating the intricate landscape of study design and execution. This expertise, combined with medical and scientific proficiency, enables us to navigate the complexities of different therapeutic areas with precision, proactively manage biases, address diverse stakeholder needs, and deliver robust and reliable outcomes for our clients. Our experience includes (in the last five years):
- 300+ studies
- 190,000+ subjects
- 9,000+ sites
- 70+ interventional studies
- 200+ non-interventional studies
- 60+ scientific advisory projects
Dedicated Partnership
At Syneos Health, we commit to being your dedicated partners in every phase of your project or study. Through strong strategic collaboration, we work hand-in-hand with you to design tailored solutions that mitigate risks and optimize outcomes.
Proactive Solutioning
We understand the complexity inherent in real world studies and work with you to identify the best solutions before study starts and throughout implementation. From inception to completion, we have the demonstrated expertise and agility to scale operations to meet your needs.
Navigate the regulatory landscape with confidence
At Syneos Health, we prioritize data quality and accuracy above all else to ensure real, reliable insights. With extensive experience in conducting late phase studies and creating evidence generation plans, we optimize your study design within regulatory frameworks that ensure a seamless journey from study conceptualization to compliance.